Stock search

Ticker or company name

DXCM card

DXCM price forecast

Dexcom$81,61

P/E now is 32,1. Average over 5 years: 103,7 (range 42–148). The stock is 69% below its history.

Base · FY2030

$361,91+43,6% a year

The base case gives 43,6% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$5,56 bn$6,64 bn$7,92 bn$9,45 bn$11,3 bn
Net income$726 m$866 m$1,03 bn$1,23 bn$1,47 bn
EPS$1,78$2,10$2,49$2,95$3,49

Changed values are highlighted. Bear and bull cases: growth ∓ 6,4%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $81,61

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$93,44

Price change
+14,5%
A year
+3,3%
Fair value today
$63,10
Margin of safety
−22,7%

Base$361,91

Price change
+343,5%
A year
+43,6%
Fair value today
$244,39
Margin of safety
+199,5%

Bull$775,02

Price change
+849,7%
A year
+72,7%
Fair value today
$523,35
Margin of safety
+541,3%

What growth the price implies

For the stock to return 10% a year, revenue must grow −4,2% a year to FY2030 at a 13% margin and P/E 103,7.

Growth over 5 years
19,3%
Analyst consensus
no data
In your model
19,3%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$361,91+43,6% a year